March 26 2019 - DOJ supports Trump’s ruling to strike down ACA, including biosimilar provisions
Flag link:
DOJ supports ruling to strike down ACA, including biosimilars provisions
DOJ supports ruling to strike down ACA, including biosimilars provisions
BioCentury
biosimilars
Affordable Care Act
Donald Trump
Flag link:
Falsified Data Forces Duke to Pay $112 Million Settlement, Other Universities Under Scrutiny as Well
Falsified Data Forces Duke to Pay $112 Million Settlement, Other Universities Under Scrutiny as Well
BioSpace
Duke University
NIH
Flag link:
Bluebird opens manufacturing facility as it moves gene therapies forward
Bluebird opens manufacturing facility as it moves gene therapies forward
Fierce Pharma
Bluebird Bio
gene therapy
cell therapy
drug manufacturing
Flag link:
Alexion chief registers $16.5M in pay after a solid year, with a relatively low 74-to-1 ratio compared to a well paid staff
Alexion chief registers $16.5M in pay after a solid year, with a relatively low 74-to-1 ratio compared to a well paid staff
Endpoints
Alexion
Pharma CEOs
executive pay
Ludwig Hantson
Flag link:
Purdue Pharma, maker of OxyContin, settles opioids lawsuit in Oklahoma
Purdue Pharma, maker of OxyContin, settles opioids lawsuit in Oklahoma
Stat
Oklahoma
Purdue Pharma
opioids
Flag link:
Sanofi may airlift medicines into UK after Brexit
Sanofi may airlift medicines into UK after Brexit
Pharmaforum
Sanofi
UK
Europe
Brexit
vaccines
flu vaccines
Flag link:
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
Xconomy
Aldeyra Therapeutics
clinical trials
FDA
eye health
reproxalap
seasonal allergic conjunctivitis
Flag link:
Bristol-Myers Gets FTC Request for More Information on $74 Billion Celgene Deal
Bristol-Myers Gets FTC Request for More Information on $74 Billion Celgene Deal
TheStreet.com
SEC
FTC
M&A
Bristol-Myers Squibb
Celgene
Flag link:
How One Company Is Using AI To Address Mental Health
How One Company Is Using AI To Address Mental Health
Forbes
mental health
wearables
devices
BioBeats
artificial intelligence
Flag link:
Microbiome Report for week ending 3/23/19
Microbiome Report for week ending 3/23/19
CP Wire
microbiome
Enterome
Rebiotix
Symbiotix Biotherapies
Flag link:
NGM Biopharmaceuticals Updates IPO Filing – Will Raise Over $122 Million
NGM Biopharmaceuticals Updates IPO Filing – Will Raise Over $122 Million
CP Wire
NGM Biopharmaceuticals
IPOs
Merck
NASH
Flag link:
Bayer and J&J settle Xarelto lawsuits in US
Bayer and J&J settle Xarelto lawsuits in US
Pharmaforum
Bayer
JNJ
Xarelto
Flag link:
Microbiome Report for week ending 3/23/19
microbiome
Enterome
Rebiotix
Symbiotix Biotherapies
Flag link:
NGM Biopharmaceuticals Updates IPO Filing – Will Raise Over $122 Million
NGM Biopharmaceuticals
IPOs
Merck
NASH
Flag link:
Allergan taps Celgene vet Hugin for M&A guidance, but proxy brawlers aren't impressed
Allergan taps Celgene vet Hugin for M&A guidance, but proxy brawlers aren't impressed
Fierce Pharma
Allergan
investors
M&A
Bob Hugin
Flag link:
Avanir's AVP-786 meets in Phase III for Alzheimer's agitation
Avanir's AVP-786 meets in Phase III for Alzheimer's agitation
BioCentury
Avanir Pharmaceuticals
AVP-786
Alzheimer's disease
Alzheimer's agitation
Flag link:
FDA clears Genetesis’ CardioFlux biomagnetic cardiac imager
FDA clears Genetesis’ CardioFlux biomagnetic cardiac imager
Mass Device
Genetesis
FDA
CardioFlux cardiac imaging platform
cardiac imaging
devices
Flag link:
What's Next for Lexicon Pharmaceuticals?
What's Next for Lexicon Pharmaceuticals?
Motley Fool
Lexicon Pharmaceuticals
sotagliflozin
Zynquista
Sanofi
diabetes
Flag link:
A Smart Toilet Seat to Detect Congestive Heart Failure
A Smart Toilet Seat to Detect Congestive Heart Failure
BioSpace
congestive heart failure
devices
Heart Health Intelligence
Flag link:

Pages